Patent Assignment
Reel/Frame 025672/0418
Assignment of Assignor's Interest
Recorded: 2011-01-20
Pages: 5
Assignor
VELA PHARMAZEUTISCHE ENTWICKLUNG UND LABORANALYTIK GMBH
Executed: 2009-09-07
Assignee
MERIDIAN BIOPHARMACEUTICALS GMBH
BRUNNER STRASSE 69/OBJEKT 3, WIEN, 1230, AUSTRIA
Covered Property
(1)
Method of Treating Lewis Y-Expressing Tumors
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 4, 2010
From: SCHUSTER, MANFRED; HIMMLER, GOTTFRIED; WAXENECKER, GUENTER; MUDDE, GEERT C.
To: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG
Reel/Frame 024489/0676 →
Certificate of Appointment
Jan 20, 2011
From: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-GMBH
To: HOCHEGGER, HERBERT, DR.
Reel/Frame 025671/0795 →
Change of Name
Jan 20, 2011
From: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG
To: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-GMBH
Reel/Frame 025672/0254 →
Assignment of Assignor's Interest
Jan 20, 2011
From: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-GMBH
To: GREENOVATION BIOTECH GMBH; VELA PHARMAZEUTISCHE ENTWICKLUNG UND LABORANALYTIK GMBH
Reel/Frame 025672/0410 →
Assignment of Assignor's Interest
Jan 31, 2011
From: LOIBNER, HANS
To: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG
Reel/Frame 026329/0262 →
Consulting Agreement
Jan 31, 2011
From: LOIBNER, HANS
To: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG
Reel/Frame 025722/0761 →